General Information of Drug (ID: DM6TYQ5)

Drug Name
8H9 I-124 mAb
Indication
Disease Entry ICD 11 Status REF
Glioma 2A00.0 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0TN4M

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)